Mark M. Perry
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Extracellular vesicles in disease
Papers in
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 7
-
- Asthma and respiratory diseases 5
- Co-authors
- Mark A. Lindsay (11 shared papers)Andrew Evan Williams (9 shared papers)Sterghios Athanasios Moschos (6 shared papers)Hanna Larner-Svensson (5 shared papers)Kian Fan Chung (12 shared papers)Ian Michael Adcock (11 shared papers)Peter John Barnes (2 shared papers)Eleni Tsitsiou (4 shared papers)
- Journals
- Epigenomics (3 papers)European Respiratory Journal (2 papers)FEBS Letters (2 papers)American Journal of Respiratory Cell and Molecular Biology (2 papers)BMC Genomics (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Mark M. Perry
26 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 1.2k
- Molecular Biology 1.4k
- Immunology 379
- Physiology 277
- Pulmonary and Respiratory Medicine 298
Countries citing papers authored by Mark M. Perry
This map shows the geographic impact of Mark M. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Perry more than expected).
Fields of papers citing papers by Mark M. Perry
This network shows the impact of papers produced by Mark M. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Perry. The network helps show where Mark M. Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark M. Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 400 | |
| 2 | 2007 | 298 | |
| 3 | 2007 | 252 | |
| 4 | 2008 | 184 | |
| 5 | 2009 | 167 | |
| 6 | 2006 | 144 | |
| 7 | 2013 | 131 | |
| 8 | 2009 | 100 | |
| 9 | 2016 | 91 | |
| 10 | 2011 | 78 | |
| 11 | 2007 | 75 | |
| 12 | 2010 | 70 | |
| 13 | 2014 | 62 | |
| 14 | 2016 | 58 | |
| 15 | 2014 | 56 | |
| 16 | 2015 | 50 | |
| 17 | 2015 | 46 | |
| 18 | 2015 | 43 | |
| 19 | 2018 | 23 | |
| 20 | 2018 | 22 |
About Mark M. Perry
Mark M. Perry is a scholar working on Cancer Research, Physiology, Molecular Biology, Immunology and Oncology, having authored 26 papers that have together received 2.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers), Asthma and respiratory diseases (5 papers), Muscle Physiology and Disorders (4 papers), Circular RNAs in diseases (3 papers), IL-33, ST2, and ILC Pathways (2 papers), Epigenetics and DNA Methylation (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.4k citations), Immunology (379 citations), Physiology (277 citations) and Pulmonary and Respiratory Medicine (298 citations). Mark M. Perry has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Mark A. Lindsay, Andrew Evan Williams, Sterghios Athanasios Moschos, Hanna Larner-Svensson, Kian Fan Chung, Ian Michael Adcock, Peter John Barnes, Eleni Tsitsiou, Jonas S. Erjefält and Maria Gabriela Belvisi. Their work appears in journals such as Epigenomics, European Respiratory Journal, FEBS Letters, American Journal of Respiratory Cell and Molecular Biology and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.